TGF-β in T Cell Biology: Implications for Cancer Immunotherapy

Area of Science:

• Immunology
• Cancer Biology
• Molecular Biology

Background:

• Transforming Growth Factor beta (TGF-β) is abundant in tumor microenvironments, often hindering anti-cancer T-cell responses.
• TGF-β inhibits T-cell proliferation, activation, and effector functions, promoting tumor progression.
• It also drives regulatory T-cell differentiation, enhancing immunosuppression in tumors.

Purpose of the Study:

• To review the complex roles of TGF-β in T-cell biology within the tumor microenvironment.
• To explore how TGF-β influences different T-cell subsets relevant to cancer immunity.
• To discuss potential strategies for manipulating TGF-β signaling to enhance cancer immunotherapy.

Main Methods:

• Literature review of current research on TGF-β and T-cell interactions in cancer.
• Analysis of studies investigating TGF-β's dual effects on T-cell differentiation and function.
• Synthesis of findings to evaluate therapeutic implications for cancer immunotherapy.

Main Results:

• TGF-β generally suppresses T-cell immunosurveillance, inhibiting proliferation and effector functions.
• Paradoxically, TGF-β can induce differentiation of pro-tumor T-cell subsets like Th17, Th9, and Trm cells.
• These inflammatory T-cell populations have been linked to better tumor control in certain models.

Conclusions:

• TGF-β exhibits context-dependent functions in tumor immunity, with both immunosuppressive and potential pro-immune roles.
• Understanding these dual roles is crucial for developing effective cancer immunotherapies.
• Targeting TGF-β signaling pathways may offer novel strategies to restore anti-tumor immunity.